Candida glabrata colonizes but does not often disseminate from the mouse caecum.

Candida glabrata is the second or third most frequent cause of candidaemia. The gastrointestinal tract is considered to be a major portal of entry for systemic candidiasis, but relatively few studies have investigated the pathogenesis of C. glabrata. Experiments were designed to clarify the ability of C. glabrata to disseminate from the mouse intestinal tract. Following oral inoculation, C. glabrata readily colonized the caeca [approx. 10(7) cells (g caecum)(-1)] of antibiotic-treated mice, but extraintestinal dissemination was not detected. Superimposing several mouse models of trauma and/or immunosuppression known to induce dissemination of Candida albicans and other intestinal microbes did not cause C. glabrata to disseminate often, although one exception was mice given high doses of dexamethasone for 4 days. These data support the hypothesis that the antibiotic-treated mouse intestine may be an epidemiological reservoir for C. glabrata and that this yeast tends to disseminate under specific clinical conditions.

[1]  M. Cantorna,et al.  Mucosal and systemic candidiasis in congenitally immunodeficient mice , 1990, Infection and immunity.

[2]  J. Sobel,et al.  Candida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison toC. albicans , 1999, Clinical Microbiology Reviews.

[3]  S. Wiesner,et al.  Cecal Colonization and Systemic Spread of Candida albicans in Mice Treated with Antibiotics and Dexamethasone , 2002, Pediatric Research.

[4]  K. Tateda,et al.  Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice. , 2001, Journal of medical microbiology.

[5]  J. F. Brown,et al.  Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. , 1994, Journal of immunology.

[6]  L. Saiman,et al.  National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  J. Brieland,et al.  Comparison of Pathogenesis and Host Immune Responses to Candida glabrata and Candida albicans in Systemically Infected Immunocompetent Mice , 2001, Infection and Immunity.

[8]  A. Kim,et al.  Hypoxia and Extraintestinal Dissemination of Candida Albicans Yeast Forms , 2002, Shock.

[9]  R. Simmons,et al.  Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria , 1987, Infection and immunity.

[10]  O. Ekenna,et al.  Factors affecting colonization and dissemination of Candida albicans from the gastrointestinal tract of mice , 1987, Infection and immunity.

[11]  H. Matsuda,et al.  Mild hypotension and body burns synergistically increase bacterial translocation in rats consistent with a "two-hit phenomenon". , 1997, The Journal of burn care & rehabilitation.

[12]  N. Gürler,et al.  The effect of surgical trauma on the bacterial translocation from the gut. , 1992, Journal of pediatric surgery.

[13]  S. Tzipori,et al.  Intestinal Lesions Associated with Disseminated Candidiasis in an Experimental Animal Model , 2000, Journal of Clinical Microbiology.

[14]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  I. Chaudry,et al.  Sex steroid-mediated regulation of macrophage/monocyte function in a two-hit model of trauma-hemorrhage and sepsis. , 2004, Cytokine.

[16]  K. Haynes,et al.  Candida glabrata displays pseudohyphal growth. , 2000, FEMS microbiology letters.

[17]  R. Berg,et al.  Endotoxin‐induced bacterial translocation and mucosal permeability: Role of xanthine oxidase, complement activation, and macrophage products , 1991, Critical care medicine.

[18]  L. Magnotti,et al.  Burns, bacterial translocation, gut barrier function, and failure. , 2005, The Journal of burn care & rehabilitation.

[19]  D. Hess,et al.  Effect of lipopolysaccharide on virulence of intestinal candida albicans. , 2003, The Journal of surgical research.

[20]  J. Alexander,et al.  The process of microbial translocation. , 1990, Annals of surgery.

[21]  E. Bedner,et al.  Effects of WR-2721 and cyclophosphamide on the cell cycle phase specificity of apoptosis in mouse bone marrow , 2002, Anti-cancer drugs.

[22]  W. Powderly,et al.  A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  E Balish,et al.  Effect of oral tetracycline, the microbial flora, and the athymic state on gastrointestinal colonization and infection of BALB/c mice with Candida albicans , 1979, Infection and immunity.

[24]  D. Hess,et al.  Comparative virulence of Candida albicans yeast and filamentous forms in orally and intravenously inoculated mice , 2003, Critical care medicine.

[25]  C Washington Winn,et al.  Koneman's Color Atlas and Textbook of Diagnostic Microbiology , 1994 .

[26]  M. Ruhnke,et al.  Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts. , 2006, Current drug targets.

[27]  E. Anaissie,et al.  The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  M. J. Kennedy,et al.  Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism , 1985, Infection and immunity.

[29]  L. Leibovici,et al.  Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. , 2005, The Journal of hospital infection.

[30]  J. Vincent,et al.  Potential risk factors for infection with Candida spp. in critically ill patients. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  S. Filler,et al.  Mice with disseminated candidiasis die of progressive sepsis. , 2005, The Journal of infectious diseases.

[32]  B. D. de Pauw,et al.  Impaired gut function as risk factor for invasive candidiasis in neutropenic patients , 2002, British journal of haematology.

[33]  F. Colardyn,et al.  Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata. , 2001, The Journal of hospital infection.

[34]  R. Berg,et al.  Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii. , 1993, The Journal of infectious diseases.

[35]  Stephen M. Wiesner,et al.  Gastrointestinal Colonization by Candida albicans Mutant Strains in Antibiotic-Treated Mice , 2001, Clinical Diagnostic Laboratory Immunology.

[36]  I. Chaudry,et al.  Androstenediol ameliorates alterations in immune cells cytokine production capacity in a two-hit model of trauma-hemorrhage and sepsis. , 2006, Cytokine.